✦ LIBER ✦

Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V leiden

✍ Scribed by Ilene C. Weitz; Valerie K. Israel; Howard A. Liebman

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 65 KB
Volume: 79
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19970515)79:10<2024::aid-cncr25>3.0.co;2-v

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

Thromboembolic events are well recognized complications of can-

📜 SIMILAR VOLUMES

Activated protein C resistance and the f

Activated protein C resistance and the factor V Leiden mutation in children with thrombosis

✍ Sifontes, Maria T.; Nuss, Rachelle; Hunger, Stephen P.; Waters, Jill; Jacobson, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 22 KB 👁 2 views

To determine the prevalence of activated protein C resistance and the factor V Leiden mutation (position 1691, arginine 506 to glutamine substitution) in children with thrombosis, plasma samples from children with thrombosis were tested for activated protein C resistance. DNA was analyzed for the fa

Resistance to activated protein C in uns

Resistance to activated protein C in unselected patients with arterial and venous thrombosis

✍ Faioni, Elena M.; Razzari, Cristina; Martinelli, Ida; Panzeri, Daniela; Franchi, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

Four hundred and ninety-three consecutive patients referred for arterial or venous thrombosis were screened for congenital and acquired abnormalities of blood coagulation predisposing to thrombosis, and were compared to 341 age-and sex-matched controls. The aim of the study was to determine the prev

High prevalence of activated protein C r

High prevalence of activated protein C resistance due to factor V leiden mutation in cases of intrauterine fetal death

✍ H. Rothbart; G. Ohel; J. Younis; N. Lanir; B. Brenner 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB 👁 1 views

## Objective: To test a possible association between activated protein C resistance and intrauterine fetal death. Methods: The activated protein C anticoagulant activity and factor V R506Q mutation were assessed in 14 nonpregnant women with a history of intrauterine fetal death and 14 healthy cont

Detection of a common mutation in factor

Detection of a common mutation in factor V gene responsible for resistance to activated protein C causing predisposition to thrombosis

✍ A. Ferreira-Gonzalez; LM Fisher; CM Lehman; MH Langley; DH Lofland; Q Xia; NX Ng 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Hereditary predisposition to thrombosis due to activated protein C resistance (APCR) has been attributed to a missense mutation in the factor V gene at nucleotide 1691 (G to A), causing replacement of arginine at codon 506 with glutamine. Using an RFLP-PCR assay to detect this mutation, we measured

Mesenteric vein thrombosis secondary to

Mesenteric vein thrombosis secondary to combined protein C deficiency and double heterozygosity for factor V leiden and prothrombin G20210A

✍ Hertzberg, M.S.; Underwood, T.; Favaloro, E.J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

To the Editor: Hb S (␤6 Glu-Val), Hb D Los Angeles (␤121 Glu-Gln) and Hb O Arab (␤121 Glu-Lys) are the most common variants in Turkish population including Turkish Cypriots [1,2]. Either during screening of the population or to enlighten the reason of anemia; several abnormal hemoglobin variants can